Nigel H Greig Selected Research

Nigel H Greig Research Topics

Disease

108	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2002
34	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021 - 03/2002
30	Parkinson Disease (Parkinson's Disease) 01/2022 - 11/2002
26	Neuroinflammatory Diseases 04/2022 - 09/2007
22	Type 2 Diabetes Mellitus (MODY) 01/2020 - 03/2002
21	Inflammation (Inflammations) 04/2022 - 09/2007
21	Traumatic Brain Injuries (Traumatic Brain Injury) 03/2022 - 09/2011
20	Stroke (Strokes) 04/2022 - 11/2002
18	Cognitive Dysfunction 11/2022 - 11/2002
13	Neuroblastoma 12/2021 - 11/2002
13	Nervous System Diseases (Neurological Disorders) 01/2021 - 07/2012
12	Amyloid Plaque 01/2021 - 01/2002
12	Dementia (Dementias) 12/2018 - 01/2002
11	Disease Progression 01/2022 - 07/2005
11	Brain Concussion (Cerebral Concussion) 01/2020 - 10/2013
10	Neoplasms (Cancer) 04/2022 - 11/2003
5	Infarction (Infarctions) 02/2020 - 03/2007
5	Ischemic Stroke 01/2020 - 03/2010
5	Multiple Myeloma 01/2020 - 11/2003
5	Insulin Resistance 01/2019 - 06/2012
5	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2016 - 12/2004
4	Gliosis 07/2021 - 03/2015
4	Brain Injuries (Brain Injury) 02/2020 - 01/2007
4	Brain Ischemia (Cerebral Ischemia) 01/2019 - 06/2004
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2022 - 05/2009
3	Obesity 01/2020 - 06/2012
3	Hypoxia (Hypoxemia) 01/2018 - 12/2004
3	Huntington Disease (Huntington's Disease) 01/2015 - 02/2009
3	Memory Disorders (Memory Loss) 01/2013 - 07/2012
2	Schizophrenia (Dementia Praecox) 01/2021 - 01/2015
2	Mental Disorders (Mental Disorder) 01/2021 - 08/2015
2	Dyskinesias (Dyskinesia) 01/2020 - 12/2019
2	Craniocerebral Trauma (Head Injury) 01/2020 - 09/2007
2	Contusions 09/2019 - 01/2019
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 04/2019 - 07/2012

Drug/Important Bio-Agent (IBA)

41	Pharmaceutical PreparationsIBA 04/2022 - 02/2003
39	Proteins (Proteins, Gene)FDA Link 04/2021 - 03/2002
28	Amyloid (Amyloid Fibrils)IBA 11/2022 - 12/2004
25	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2021 - 03/2002
24	Peptides (Polypeptides)IBA 02/2022 - 01/2002
20	Exenatide (Byetta)FDA Link 01/2020 - 03/2002
20	Amyloid beta-PeptidesIBA 01/2017 - 01/2002
18	phenserineIBA 02/2020 - 12/2004
16	CytokinesIBA 01/2022 - 01/2004
15	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2020 - 11/2002
15	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2019 - 11/2003
14	Thalidomide (Thalomid)FDA Link 04/2021 - 11/2003
14	Glucagon-Like Peptide-1 ReceptorIBA 01/2017 - 03/2002
13	Cholinergic Agents (Cholinergics)IBA 02/2022 - 05/2004
12	Neuroprotective AgentsIBA 01/2022 - 11/2002
12	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 03/2002
12	ButyrylcholinesteraseIBA 01/2017 - 01/2002
11	AcetylcholinesteraseIBA 02/2020 - 05/2004
10	pomalidomideIBA 04/2022 - 07/2013
9	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2008
9	3,6'-dithiothalidomideIBA 12/2019 - 09/2011
9	Blood Glucose (Blood Sugar)IBA 01/2017 - 09/2002
7	pifithrinIBA 01/2020 - 11/2002
6	Glutamic Acid (Glutamate)FDA Link 12/2021 - 12/2004
6	IncretinsIBA 06/2020 - 06/2010
6	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 03/2020 - 01/2006
6	Rivastigmine (Exelon)FDA LinkGeneric 03/2020 - 01/2002
6	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2015
5	SynucleinsIBA 04/2022 - 03/2011
5	Immunomodulating AgentsIBA 07/2021 - 01/2019
5	Messenger RNA (mRNA)IBA 01/2020 - 11/2002
5	tartaric acid (tartrate)FDA Link 01/2020 - 07/2005
5	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2014 - 07/2005
4	Caspase 3 (Caspase-3)IBA 03/2022 - 03/2005
4	Biological ProductsIBA 01/2022 - 07/2003
4	Oxidopamine (6 Hydroxydopamine)IBA 01/2020 - 07/2018
4	Glucagon-Like Peptide-1 Receptor AgonistsIBA 04/2019 - 12/2004
4	AntioxidantsIBA 10/2018 - 01/2007
4	Insulin (Novolin)FDA Link 01/2018 - 03/2002
4	LipopolysaccharidesIBA 01/2018 - 01/2011
4	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 03/2014 - 06/2012
4	EnzymesIBA 01/2014 - 08/2006
4	Cholinesterases (Cholinesterase)IBA 08/2013 - 07/2005
4	CarbamatesIBA 06/2012 - 02/2005
3	alpha-SynucleinIBA 01/2022 - 03/2009
3	Lenalidomide (CC 5013)FDA Link 01/2019 - 07/2013
3	Transcription Factors (Transcription Factor)IBA 01/2018 - 06/2004
3	Hormones (Hormone)IBA 01/2018 - 03/2002
3	Therapeutic UsesIBA 01/2018 - 01/2016
3	Oxygen (Dioxygen)IBA 12/2017 - 01/2014
3	Hypoglycemic Agents (Hypoglycemics)IBA 05/2017 - 02/2009
3	Amyloidogenic ProteinsIBA 01/2015 - 02/2005
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2014 - 11/2005
3	PhysostigmineIBA 07/2010 - 02/2005
3	IronIBA 03/2009 - 11/2002
3	Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA 01/2007 - 10/2002
2	ChemokinesIBA 01/2022 - 01/2020
2	KATP ChannelsIBA 01/2021 - 01/2010
2	Complement System Proteins (Complement)IBA 01/2021 - 01/2020
2	Presenilin-1IBA 01/2021 - 07/2009
2	Levodopa (L Dopa)FDA LinkGeneric 01/2020 - 12/2019
2	Glucagon (Glukagon)FDA Link 01/2020 - 04/2019
2	BenserazideIBA 01/2020 - 12/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 10/2018

Therapy/Procedure

15	Therapeutics 04/2022 - 01/2002